1,048 results on '"Cândida"'
Search Results
2. Über Schnelltests und Labordiagnostik.
- Author
-
Egert, Gabriele and Ambrosch, Andreas
- Subjects
- *
CLINICAL pathology , *MYCOLOGY , *PATHOGENIC microorganisms , *CANDIDA , *TRANSPLANTATION of organs, tissues, etc. - Abstract
The article focuses on advancements in rapid tests and laboratory diagnostics in mycology, emphasizing their role in promptly identifying fungal infections through immunological and molecular methods. It states that these technologies allow for quicker detection and differentiation of pathogens like Aspergillus and Candida, crucial for timely intervention, especially in immunocompromised patients undergoing treatments such as organ transplants or immunosuppressive therapies. more...
- Published
- 2024
Catalog
3. New kid on the block.
- Author
-
Ambrosch, Andreas
- Subjects
- *
CANDIDA , *STRINGENT control (Bacteria) , *HOSPITALS ,MORTALITY risk factors - Abstract
The article focuses on the increasing prevalence of Candida auris infections in German hospitals, highlighting concerns over its resistance patterns and the necessity for stringent prevention measures since its notification became mandatory in 2023. It states that despite primarily causing colonizations, the fungus poses significant challenges due to high mortality rates associated with invasive infections and its resistance to multiple antifungal classes. more...
- Published
- 2024
- Full Text
- View/download PDF
4. Die Klein-Seerose, Nymphaea candida (Nymphaeaceae), ein Wiederfund für die Steiermark.
- Author
-
FRANZ, Wilfried Robert and HOCHLEITNER, Peter
- Subjects
- *
WATER lilies , *NATURE reserves , *CANDIDA , *SPECIES - Abstract
Until recently Nymphaea candida was thought to have become extinct in Styria. During short visits in July 2015 and 2016 to the Furtner Teich Natura 2000 Protected Area in the Zirbitzkogel-Grebenzen Natural Park near Neumarkt in the Murau District of Styria, Nymphaea blossoms of water lilies were also observed and the occurrence of N. candida was suspected by W.R. Franz. In 2020 P. Hochleitner was able to confirm the occurence of both N. alba and N. candida species at the Furtner Teich site. Morphological features of both Nymphaea species are listed and compared and the currently knwon distribution in Austria of N.candida is discussed. [ABSTRACT FROM AUTHOR] more...
- Published
- 2022
5. Wohnbilder: Bewohnbare Architektur und Photographie.
- Author
-
Figal, Günter
- Subjects
ARCHITECTURAL photography ,PHOTOGRAPHS ,CANDIDA ,ARTISTS ,SOCIAL dominance ,PICTURES - Abstract
In this essay, I wish to elucidate the specific function architectural photography has for the experience of buildings. With photographs, the image character of buildings can be discovered and represented, and thereby the nature of habitation can be revealed as well. Taking or contemplating pictures of habitable rooms one could learn that habitation is primarily perceptional—a character mostly concealed by the dominance of everyday practice. In order to give an impression of the manifold possibilities architectural photography holds, I discuss the work of five quite different photographic artists, namely Julius Shulman, Yutaka Saito, Candida Höfer, Cy Twombly, and Yasuhiro Ishimoto. [ABSTRACT FROM AUTHOR] more...
- Published
- 2021
6. Update Vaginalmykose.
- Author
-
Hof, Herbert
- Abstract
Copyright of Der Gynäkologe is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2020
- Full Text
- View/download PDF
7. Psoriasis intertriginosa.
- Author
-
Thomas, C., Matthies, M., Homey, B., and Meller, S.
- Abstract
Copyright of Der Hautarzt is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2020
- Full Text
- View/download PDF
8. „Black esophagus“ – zwei Obduktionsfälle mit infektiöser Beteiligung
- Author
-
Stock, Benjamin, Möckel, Sigrid, Zander, Christine, Heinsen, Helmut, Bohnert, Simone, and Bohnert, Michael
- Published
- 2022
- Full Text
- View/download PDF
9. [Endogenous Candida endophthalmitis].
- Author
-
Huth A, Roth M, and Viestenz A
- Subjects
- Humans, Prognosis, Bacteria, Candida, Vitrectomy, Endophthalmitis diagnosis
- Abstract
Endogenous Candida endophthalmitis is a rare but vision-threatening disease. In most cases, endogenous endophthalmitis caused by Candida species has a better prognosis than endogenous endophthalmitis caused by other fungal species or bacteria but the prognosis still depends heavily on the time required for diagnosis and subsequent treatment as well as the initial visual acuity. Suggestions for treatment algorithms have already been made in the past but binding guidelines in ophthalmology only exist sporadically due to the rarity of the disease. This review discusses the current knowledge on endogenous Candida endophthalmitis and draws conclusions from the current study situation., (© 2024. The Author(s).) more...
- Published
- 2024
- Full Text
- View/download PDF
10. Das Deutsche Pilz-Keratitis-Register: Erste Ergebnisse einer multizentrischen Erhebung.
- Author
-
Roth, M., Daas, L., Renner-Wilde, A., Cvetkova-Fischer, N., Saeger, M., Herwig-Carl, M., Matthaei, M., Fekete, A., Kakkassery, V., Walther, G., von Lilienfeld-Toal, M., Mertens, C., Lenk, J., Mehlan, J., Fischer, C., Fuest, M., Kroll, S., Bayoudh, W., Viestenz, A., and Frings, A. more...
- Abstract
Copyright of Der Ophthalmologe is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2019
- Full Text
- View/download PDF
11. Antimycotic resistance in German \(Candida\) \(auris\) isolates
- Author
-
Ebner, Sebastian Manfred
- Subjects
Wirkstoff ,Resistenz ,%22">Hospitalismus ,Behandlung ,ddc:610 ,610 Medizin und Gesundheit ,Candida - Abstract
Bei dem 2009 erstbeschriebenen Hefepilz C. auris handelt es sich um einen Keim, welcher aufgrund von nosokomialen Ausbrüchen und hohen Antimykotikaresistenzen Aufmerksamkeit erregte. Ziel dieser Arbeit war es in Deutschland gesammelte Isolate bezüglich vorhandener Resistenzen und Mutationen in Resistenzregionen zu testen und das epidemiologische Geschehen hierzulande mit dem globalen Auftreten des Keims zu vergleichen. Bezüglich der durchgeführten Resistenztestungen wiesen die CLSI-konformen Testarten (YO-Platten und E-Test-Verfahren) meist vergleichbare Ergebnisse auf. Für das EUCAST-konforme Mikrodilutionstestverfahren kann aufgrund eines stark ausgeprägten paradoxen Wachstumseffekts nur Anidulafungin, nicht jedoch Caspofungin, zur Testung empfohlen werden. Insgesamt erwiesen sich 25 % der Isolate als Caspofungin-resistent. Zwei Isolate zeigten eine Resistenz gegenüber allen getesteten Echinocandinen (16,7 %). Die höchsten Resistenzraten wurden gegenüber Fluconazol (92 %) beobachtet. Zwei der Isolate zeigten sich gegenüber Voriconazol resistent (16,7 %). Für Amphotericin B konnte eine Resistenzrate von 33,3 % festgestellt werden. Für die Wirkstoffe Posaconazol und Itraconazol erwiesen sich alle untersuchten Isolate als sensitiv. Dies konnte auch mit Ausnahme eines Isolates für 5-Flucytosin beobachtet werden. Die durch eine Sanger-Sequenzierung erhaltenen Sequenzen der Gene FKS1 und ERG11 wurden auf Mutationen untersucht, welche zu Aminosäuresubstitutionen im Gesamtprotein führten. Hierbei ergaben sich für zwei Isolate (16,7 %) Mutationen im FKS1-Hot Spot 1 (Typ S639F und S639Y). Beide Isolate zeigten sich in den AFST Echinocandin-resistent. Bei allen untersuchten Isolaten lagen Mutationen im ERG11 Gen vor. So fand sich in 8 Fällen eine Mutation des Typen Y132F (66,7 %), in 3 Fällen der Typ K143R (25 %) und in einem Fall der Typ F126L (8,3 %). Im Rahmen eines anderen Projekts wurde mit den hier gewonnenen PCR-Produkten ein WGS durchgeführt, um die Isolate durch SNPs-Vergleich mit Referenzstämmen phylogenetischen Clades zuzuordnen. Dabei konnten 91,7 % der Isolate dem südasiatischen Clade I und ein Isolat dem südafrikanischen Clade III zugeordnet werden. Aufgrund der geringen epidemiologischen Fallzahlen in Deutschland scheint gegenwärtig keine Bedrohung von C. auris auszugehen. Berichte aus anderen Ländern konnten allerdings eine rasche, ausbruchartige Zunahme von C. auris Fällen nachweisen. So kann nur angeraten werden das infektiologische Geschehen in Deutschland weiterhin zu beobachten., The fungus C. auris was first described in the year 2009. Because of a high number of nosocomial outbrakes and high antimycotic resistance rates the fungus attracted great media attention. The aim of this dissertion was to test German isolates for antimycotic resistance and mutations in resistance genes. Additionally, the epidemiological occurrence in Germany was compared to the global outspread. In this context CLSI-conform methods for resistance testing (YO-Plates and E-Test-Plates) generated comparable results. The testing of EUCAST-conform microdilution plates showed a strong paradoxical growth for Caspofungin. Because of this only Anidulafungin can be recommended for testing. In summary 25 % of the isolates were resistant against Caspofungin. Two isolates showed resistance against all tested Echinocandines (16,7 %). The highest rates were detected for Fluconazol (92 %). Furthermore, two of the isolates (16,7 %) showed resistance against Voriconazol. There was a resistance rate of 33,3 % to Amphotericin B. No isolate showed resistance against Posaconazol or Itraconazol. And only one isolate was resistant against 5-Flucytosin. Sanger-Sequencing was used to detect mutations in resistance genes FKS1 und ERG11, which could lead to a substitution of amino acids in the protein. There were two isolates (16,7 %) with mutations in FKS1-Hot Spot 1 (type S639F and S639Y). Both isolates showed a Echinocandin resistance in AFST. All tested isolates showed a mutation in ERG11. There were eight cases of type Y132F (66,7 %), three cases of K143R (25 %) and in one case type F126L (8,3 %). The PCR products of this study were used in a different project for WSG. This made it possible to group the isolates into phylogenetic clades. In summary 91,7 % of the isolates were related to Clade I (South Asia) and one isolate was related to Clade III (South Africa). Because of low epidemiologic occurence in Germany, there is little threat of servere health care issues at the moment. Reports from diffferent countries all over the world however, showed a quick, outbrake-like increase of C. auris cases. Therefore, further observation of German epidemiology is highly recommended. more...
- Published
- 2023
12. 10 Monate/w mit anogenitaler Rötung.
- Author
-
Weins, A. B. and Schnopp, C.
- Published
- 2018
- Full Text
- View/download PDF
13. Analysis of multiple resistance genes of in vitro induced resistant C. albicans and C. glabrata using targeted resequencing with multiplex long-range PCR
- Author
-
Götz, Hannah
- Subjects
Antimykotikum ,Resistenz ,Resistance ,Next Generation Sequencing ,Multiplex long-range PCR ,Antifungal ,Candida - Abstract
Einleitung Candida spezies sind opportunistische Erreger, welche Candidämien sowie invasive Candidosen auslösen können, Krankheiten mit hoher Sterblichkeitsrate. Besonders Patient*innen mit geschwächtem Immunsystem, nach Operationen und mit Kathetern sind betroffen. Über die letzten Jahre zeigte sich ein Trend ansteigender resistenter Isolate, die die Therapie erschweren. Es gibt zur Zeit nur vier Klassen von Antimykotika, die therapeutisch eingesetzt werden: Azole, Echinocandine, Pyrimidine und Polyene. Ziel der Arbeit Da das Auftreten resistenter Candida-Isolate eine relativ neue Entwicklung ist, gibt es noch viele offene Fragen zu den Resistenzmechanismen von Candida. Das Hauptziel dieser Arbeit ist es daher, mit einem in vitro Resistenzmodell resistente Isolate zu generieren, um anhand derer diese offenen Fragen zu beantworten. Darüber hinaus ist es möglich, die Resistenzmecha¬nismen mit diesen generierten Isolaten zu untersuchen. Methodik 48 Stämme von C. albicans sowie 48 Stämme von C. glabrata wurden in zwei Studiendesigns einer Langzeitexposition von 36 Tagen gegenüber sechs verschiedenen Antimykotika (Anidulafungin, Micafungin, Posaconazol, Voriconazol, 5-Flucytosin und Amphotericin B) unterzogen. Minimale Hemmkonzentrationen der Stämme wurden vor und nach Exposition bestimmt. Acht Resistenzgene pro Spezies (C. albicans: FUR1, FCY1, ERG11, ERG3, MRR1, TAC1, UPC2, GSC1, C. glabrata: FUR1, FCY1, ERG11, ERG3, FKS1, FKS2, MSH2, CgPDR1) wurden dann in einer long-range Multiplex PCR amplifiziert, bevor diese mittels Next Generation Sequencing auf Mutationen untersucht wurden. Ergebnisse Insgesamt wurde bei 39 Isolaten eine Resistenz gegen mindestens eine Antimykotika-Klasse festgestellt. Bei 29 dieser Stämme, dabei handelte es sich bei einem Stamm um C. albicans und bei 28 Stämmen um C. glabrata, wurden die zugrundliegenden Resistenzmechanismen detektiert. Die nachgewiesenen Mutationen waren lokalisiert in ERG3, FKS1, FKS2, CgPDR1 und FUR1. Von diesen insgesamt 29 verschiedenen Mutationen wurden 24 im Zuge dieser Arbeit erstmals beschrieben. Conclusio Die neu gefundene Mutation in FUR1 von C. albicans betont den Resistenzmechanismus der fehlenden Metabolisierung der Prodrug 5-Flucytosin. Für C. glabrata wurden folgende Resistenzmechanismen beschrieben: Überexpression der Drug Efflux Pumpen bei Azolen, Target Mutationen bei Echinocandinen und fehlende Metabolisierung der Prodrug 5-Flucytosin. Die Relevanz von ERG3 bei Echinocandinresistenzen wurde ebenfalls beobachtet. Introduction Candida species are opportunistic pathogens which are able to cause candidemia and invasive candidiasis, a disease with a high fatality rate. Especially patients with a compromised immune system or injuries of the internal organs due to surgeries or catheters are at risk. Over the last few years, there has been a trend of the development of resistant strains, thus complicating therapy. There are only four groups of antifungal agents available for use: azoles, echinocandins, pyrimidine analogues and polyenes. Aim of the work Since the emergence of resistant Candida isolates is a relatively new development and only few clinical isolates are available for research despite the increasing rates of resistance, there are still many open questions regarding the resistance mechanisms of Candida. Accordingly, the main aim of this work is to counteract this low number of isolates via an in vitro resistance induction model. It is furthermore possible to investigate the resistance mechanisms with a high number of those generated resistant isolates. Methods 48 C. albicans and 48 C. glabrata isolates were subjected to long-term exposure to six different antifungal agents in two study designs in order to induce resistance. These were anidulafungin, micafungin, posaconazole, voriconazole, 5-flucytosine and amphotericin B. Minimal inhibitory concentrations of the strains were measured before and after exposure. Eight genes per species (C. albicans: FUR1, FCY1, ERG11, ERG3, MRR1, TAC1, UPC2, GSC1, C. glabrata: FUR1, FCY1, ERG11, ERG3, FKS1, FKS2, MSH2, CgPDR1) were then amplified in long-range multiplex PCR before being analyzed for mutations via next generation sequencing. Results A total of 39 resistant isolates gained resistance to at least one class of antifungals. The underlying resistance mutations could be detected in 29 of them. These 29 mutated isolates consist of one C. albicans and 28 C. glabrata strains. Mutations were found in ERG3, FKS1, FKS2, CgPDR1 and FUR1. Of these 29 different mutations, 24 were described for the first time in the course of this work. Conclusion The newly detected mutation in FUR1 of C. albicans indicates that the resistance mechanism failing prodrug metabolization of 5-flucytosine is the main cause for resistance acquisition. The following resistance mechanisms could be described for C. glabrata: overexpression of drug efflux pumps in azoles, target mutations in echinocandins and failing prodrug metabolization of 5-flucytosine. It was also observed that ERG3 is of relevance to the resistance acquisition in echinocandin-resistant isolates. more...
- Published
- 2022
14. Echinocandin resistance in \(Candida\) \(glabrata\)
- Author
-
Aldejohann, Alexander Maximilian
- Subjects
Multidrug-Resistenz ,Micafungin ,Resistenzbestimmung ,Anidulafungin ,614 Inzidenz und Prävention von Krankheiten ,ddc:614 ,Candida - Abstract
Candida glabrata ist die zweithäufigste Ursache von Candidämien und invasiven Hefepilzinfektionen in Europa. Im Gegensatz zu C. albicans zeigt C. glabrata eine reduzierte Empfindlichkeit gegen bestimmte Antimykotika und kann unter Therapie rasch Resistenzen entwickeln. Diese Arbeit umfasst eine systematische geno- und phänotypische Resistenzanalyse einer der größten europäischen - durch das NRZMyk in 5 Jahren zusammengetragenen - C. glabrata Stammsammlungen bestehend aus 176 klinisch relevanter Isolate. 84 der Stämme wurden anhand Referenztestung nach EUCAST zunächst als Anidulafungin (AND) resistent eingestuft. 71 wiesen konkordante Mutationen in den für die Glucan-Synthetase kodierenden FKS-Genen auf (13 % in FKS1, 87 % in FKS2). Vor allem die Position Ser-663 (FKS2-HS1) imponierte mit signifikant erhöhten AND MHK-Werten. 11 FKS-Wildtyp-Isolate, die ursprünglich als AND resistent klassifiziert wurden, wiesen in multiplen Nachtestungen um den Breakpoint undulierende AND MHK-Werte auf. 2 FKS-Wildtyp Isolate zeigten durchgängig hohe AND MHK-Werte und mussten daher - trotz fehlender Zielgenmutationen - als resistent eingestuft werden. Diese extremen Phänotypen wurden durch einen verblindeten nationalen Ringversuch bestätigt. Über ein Drittel der Isolate war multiresistent. Stämme aus Blutstrominfektionen und Ser-663 Mutation waren mit einer erhöhten Mortalität assoziiert. Ein weiteres Kernelement war die Detektion von Azol-resistenten C. glabrata petite-Phänotypen in der Routinediagnostik. Hier wurden innerhalb von 8 Monaten 20 relevante Isolate identifiziert. Die Ergebnisse belegen das regelmäßige Auftreten single- / multidrug-resistenter C. glabrata Isolate in Deutschland. Phänotypische Resistenztestungen können zu Fehlklassifizierung von sensiblen Isolaten führen. FKS-Genotypisierungen hingegen sind ein nützliches Tool zur Identifizierung relevanter Resistenzen. In seltenen Fällen scheint jedoch eine Echinocandin-Resistenz ohne genotypisches Korrelat möglich zu sein., Candida glabrata is the second most common cause of candidaemia and invasive yeast infections in Europe. In contrast to C. albicans, C. glabrata shows reduced susceptibility to certain antifungal agents and can rapidly acquire resistance under therapy. This work comprises a systematic geno- and phenotypic resistance analysis of one of the largest European C. glabrata strain collections - compiled by NRZMyk in 5 years - consisting of 176 clinically relevant isolates. 84 of the strains were initially classified as anidulafungin (AND) resistant by reference testing according to EUCAST. 71 showed concordant mutations in FKS genes encrypting the glucan synthetase (13 % in FKS1, 87 % in FKS2). In particular, the position Ser-663 (FKS2-HS1) impressed with significantly increased AND MIC-values. 11 FKS wild-type isolates, originally classified as AND resistant, showed fluctuating AND MIC-values near the clinical breakpoint after retests with multiple assays. Two FKS wild-type isolates showed consistently high AND MIC values and therefore had to be classified as resistant - despite the absence of target gene mutations. These extreme phenotypes were confirmed in a blinded national ring trial. More than one third of echinocandin-resistant isolates showed concordant fluconazole resistance. Strains from bloodstream infections and Ser-663 mutation were associated with high mortality. Another core element was the detection of azole-resistant C. glabrata petite phenotypes in routine diagnostics. Here, 20 relevant isolates were identified within 8 months, which could be assigned to 8 patients. These results demonstrate the regular occurrence of single- / multidrug-resistant C. glabrata isolates in Germany. Phenotypic resistance testing can lead to misclassification of susceptible isolates. FKS genotyping, on the other hand, is a useful tool for identifying resistant strains. However, in rare cases, echinocandin resistance without a genotypic correlate seems to be possible. more...
- Published
- 2022
- Full Text
- View/download PDF
15. Impact of the sphingolipid synthesis inhibitor myriocin on viability and antifungal susceptibility of \(Candida\) \(auris\)
- Author
-
Stieber, Hanna
- Subjects
Sphingolipidstoffwechsel ,Sphingolipide ,pathogene Pilze ,Multiresistenz ,ddc:610 ,610 Medizin und Gesundheit ,Candida - Abstract
Candida Spezies gehören als kommensale Organismen zur normalen menschlichen Mikroflora, können allerdings unter bestimmten Bedingungen Krankheitswert erlangen. Limitationen in der Behandlung durch immer mehr resistente Candida Spezies und die wachsende Zahl immunsupprimierter Patienten gelten als Hauptursachen für die steigende Häufigkeit invasiver Candidosen und systemischer Candidämien. Die 2009 entdeckte Spezies C. auris stellt durch ihre zahlreichen Resistenzen, das Potential zur Auslösung nosokomialer Ausbrüche in Krankenhäusern und die schnelle Verbreitung über mehrere Kontinente eine neue Herausforderung dar. Der Bedarf an neuen Antimykotika mit anderen Wirkmechanismen und neuen Zielstrukturen ist größer denn je. Die fungale Sphingolipid-Biosynthese wurde bereits mehrfach als potenzielles Ziel antimykotischer Therapie diskutiert, allerdings bezieht sich die meiste Forschung hierzu auf C. albicans]. In vorliegender Arbeit wurden die Auswirkungen der Inhibition der Sphingolipid Biosynthese durch Myriocin auf C. auris und sein Resistenzverhalten untersucht und mit denen auf andere Candida Spezies verglichen. Sowohl die Mikrodilution als auch die Plattentropftests zeigten, dass C. auris verglichen mit anderen Candida Spezies besonders sensitiv auf die Anwesenheit von Myriocin reagierte und stärker im Wachstum gehemmt wurde. Der Survival Assay ergab für alle drei Spezies ein Absenken der CFU durch Myriocin, die Abweichungen zwischen den Stämmen waren jedoch unwesentlich. Unterschiede konnten in Vitalität und Vermehrung der verschiedenen Spezies unter Myriocineinfluss festgestellt werden. Aus der Lebend/Tot-Färbung ging hervor, dass Myriocin bei allen Stämmen zum Absterben von Candida Zellen führte, C. albicans und C. glabrata allerdings signifikant niedrigere Überlebensraten im Vergleich zu den C. auris Isolaten aufwiesen. Im Gegensatz dazu konnte mithilfe der FITC-Mikroskopie gezeigt werden, dass Candida Zellen unter Zugabe von Myriocin weniger Tochterzellen ausbildeten, was auf eine erschwerte oder zumindest verlangsamte Zellvermehrung hindeutet. Dabei schien das Wachstum der C. auris Stämme durch Myriocin deutlich eingeschränkter zu sein als das von C. albicans und C. glabrata. Durch weitere Mikroskopie und die Kombination aus Lebend/Tot Färbung mittels PI und FITC Färbung, sollte die Verteilung der toten Zellen auf Mutter- und Tochterzellen evaluiert werden. Hier konnte ein Trend zu einem vermehrten Zellsterben der Tochterzellen, vor allem für C. auris, festgestellt werden. Abschließende E-Tests für Amphotericin B, Anidulafungin und Fluconazol ergaben eine signifikante Herabsetzung der MHK für alle C. auris Isolate durch Myriocin. Die hier vorgestellten Ergebnisse und die durch mehrere Studien festgestellten Differenzen in der Sphingolipidkomposition von C. auris verglichen mit anderen Candida Spezies geben Hinweis darauf, dass Sphingolipide für Vitalität, Zellteilung und vor allem für die Wirkung einiger Antimykotika auf C. auris eine besondere, wenn nicht übergestellte Bedeutung haben könnten. Zwar wurde die Sphingolipidsynthese bereits mehrfach als potenzieller Angriffspunkt für die antifungale Therapie diskutiert, allerdings lediglich am Beispiel anderer Candida Spezies. Der Sphingolipidstoffwechsel könnte somit ein vielversprechender Ansatz für die Behandlung des sonst so therapieresistenten und lebensbedrohlichen Pilzes C. auris sein., Candida species are commensal organisms belonging to the normal human microflora, but can become pathogenic under certain conditions. Limitations in treatment due to an increasing number of resistant Candida species and the growing number of immunosuppressed patients are considered to be the main reasons for the increasing frequency of invasive candidiasis and systemic candidemia. C. auris, a species discovered in 2009, shows potential to cause nosocomial outbreaks in hospitals, limited susceptibility to numerous antifungals and a rapid spread across several continents. This leads to a need for new antifungal agents with different mechanisms of action and new targets. Fungal sphingolipid biosynthesis has been discussed several times as a potential target of antifungal therapy, however most research on this relates to C. albicans. In the present work, the effects of inhibition of sphingolipid biosynthesis by myriocin on C. auris and its impact on fungal susceptibility were investigated and compared with those on other Candida species. Both microdilution and plate droplet assays showed that C. auris was more sensitive to myriocin compared with other Candida species and showed severe growth defects. The survival assay showed a lowering of CFU by myriocin for all three species, but the differences between the strains were insignificant. Live/dead staining showed that myriocin led to the death of Candida cells in all strains, but C. albicans and C. glabrata had significantly lower survival rates compared to the C. auris isolates. In contrast, FITC microscopy showed that Candida cells produced fewer daughter cells when myriocin was added, indicating that cell proliferation was impeded or at least slowed. In this regard, the growth of C. auris strains appeared to be significantly more restricted by myriocin than that of C. albicans and C. glabrata. Further microscopy and the combination of live/dead staining using PI and FITC staining, was performed to evaluate the distribution of dead cells between mother and daughter cells. Here, a trend towards increased cell death of daughter cells, especially for C. auris, was observed. Final E-tests for amphotericin B, anidulafungin, and fluconazole revealed a significant reduction in MIC for all C. auris isolates by myriocin. These results and the differences in sphingolipid composition of C. auris compared with other Candida species established by several studies provide evidence that sphingolipids may have a special, if not superimposed, importance for viability, cell division, and especially for the suscteptibility of C. auris to some antifungals. It is true that sphingolipid synthesis has been discussed several times as a potential target for antifungal therapy, but only using other Candida species as examples. Sphingolipid metabolism could thus be a promising approach for the treatment of the therapy-resistant and life-threatening fungus C. auris. more...
- Published
- 2022
- Full Text
- View/download PDF
16. [Anti-infective treatment of fungal infections by Candida and Aspergillus].
- Author
-
Salzer HJF
- Subjects
- Humans, Antifungal Agents adverse effects, Candida, Voriconazole, Aspergillus, Candidemia, Invasive Fungal Infections, Pulmonary Aspergillosis, Candidiasis, Invasive diagnosis, Candidiasis, Invasive drug therapy
- Abstract
Background: Invasive fungal infections caused by Candida or Aspergillus are associated with a high mortality. Knowledge about the risk factors, diagnosis and treatment management is crucial for improving the survival of those affected., Objective: To give a practical overview about risk factors and treatment management of Candida and Aspergillus infections as well as providing an outlook on new antifungal agents., Material and Methods: Summary of the relevant literature and recommendations on candidemia and invasive candidiasis as well as invasive and chronic pulmonary aspergillosis., Results: The first line treatment of candidemia and invasive candidiasis are echinocandins including caspofungin, anidulafungin and micafungin. Regular blood cultures have to be taken to determine the duration of treatment. After the first negative control blood culture treatment should be continued for another 14 days. The first line treatment of invasive pulmonary aspergillosis is azoles including voriconazole and isavuconazole. The duration of treatment depends on disease severity and is recommended for 6-12 weeks. The duration of treatment for chronic pulmonary aspergillosis is 6-12 months. Therapeutic drug monitoring is recommended for voriconazole and for posaconazole. New antifungal agents including olorofim, fosmanogepix, opelconazole, rezafungin or ibrexafungerp will broaden the therapeutic spectrum in the foreseeable future., Conclusion: Knowledge about risk factors and the correct treatment management is crucial for the survival of patients with invasive fungal infections., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.) more...
- Published
- 2023
- Full Text
- View/download PDF
17. Candidurie! Was nun? : Zur Therapie von Harnwegsinfektionen durch Candida.
- Author
-
Hof, H.
- Subjects
ANTI-infective agents ,ANTIFUNGAL agents ,CANDIDA ,CANDIDIASIS ,COMPARATIVE studies ,RESEARCH methodology ,MEDICAL cooperation ,QUINOLINE ,RESEARCH ,URINARY tract infections ,YEAST ,EVALUATION research ,TREATMENT effectiveness - Abstract
Background: Yeasts are found in urine specimens relatively often, especially in the elderly and patients under treatment with broad spectrum antibiotics, i. e. especially in intensive care unit (ICU) patients. In some cases, the number of pathogens is very high, i. e. >105/ml. The clinical relevance of detecting Candida in urine is difficult to assess. In the German S3 guidelines it is apodictically stated that an ascending infection of the urinary tract by yeasts does not occur but this may undoubtedly happen in certain instances in patients at risk, for example in the elderly, in diabetic persons and in the case of foreign bodies in the urinary tract. A hematogenous spread of yeasts can lead to pyelonephritis, which accompanies candiduria. In rare cases this can be induced by prostatitis and epididymitis. Therapy is indicated in all cases when a urological manipulation is planned, particularly those with injury to the mucosal barrier, in order to prevent an intraoperative spread of pathogens.Aim: The antimicrobial agents suitable for therapy of candiduria are limited, namely flucytosine, amphotericin B, which is also used for irrigation and fluconazole.Material and Methods: The in vitro effect of nitroxoline on 100 isolates of yeasts from urine was tested by an agar diffusion test.Results: Nitroxoline exerted a good activity against all yeast isolates.Discussion: The antibiotic nitroxoline has a good antifungal activity. It achieves high concentrations in urine and in addition, it is effective at low pH as well as against pathogens in biofilms, which most antimycotics cannot achieve. Hence, nitroxoline is suitable for termination of candiduria. Foreign bodies in the urinary tract, on which biofilms are formed, should be removed whenever possible. [ABSTRACT FROM AUTHOR] more...- Published
- 2017
- Full Text
- View/download PDF
18. Psoriasis inversa.
- Author
-
Weisenseel, P. and Reich, K.
- Abstract
Copyright of Colo-Proctology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2016
- Full Text
- View/download PDF
19. Psoriasis inversa.
- Author
-
Weisenseel, P. and Reich, K.
- Abstract
Copyright of Der Hautarzt is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2015
- Full Text
- View/download PDF
20. Multiplex long-range PCR of genes for resistancy of C. albicans and C. glabrata
- Author
-
Schweitzer, Nina
- Subjects
Resistenzgene ,Resistenz ,Sequenzierung ,Candida albicans ,Polymorphismen ,Candida glabrata ,genes for resistance ,sequencing ,Candida ,polymorphism - Abstract
Einleitung C. albicans und C. glabrata können Bestandteil des humanen Mykobioms und ebenso fakultativ pathogen sein. In den letzten Jahren kam es zu vermehrten Meldungen von Antimykotikaresistenzen bei Candida-Arten. Zur Azolresistenz sind bereits mehrere Resistenzmechanismen beschrieben. Die Relevanz der einzelnen Mechanismen kann nur durch die Ermittlung aller relevanten Resistenzmechanismen eruiert werden. Die meisten Studien verfolgen den Ansatz entweder nur einzelne Resistenzgene von vielen Isolaten zu sequenzieren oder es wird das gesamte Genom einer begrenzten Anzahl an Isolaten sequenziert. Für weitere Forschungsarbeiten ist es bedeutend, die Relevanz der einzelnen Mutationen zu eruieren. Ziele Das Ziel dieser Arbeit ist die Unterscheidung zwischen kausalen Resistenzmutationen und nicht kausalen Varianzen in den Resistenzgenen von C. albicans und C. glabrata. Ebenso soll ermittelt werden, welche dieser Gene für die Ausbildung von Resistenzen relevant sind. Demnach ist es das Ziel dieser Forschungsarbeit eine einfache und schnelle Methode zu entwickeln, welche es ermöglicht, mehrere Mutationen in Resistenzgenen in einer hohen Anzahl von resistenten und sensiblen Isolaten gleichzeitig zu detektieren. Methoden In dieser Studie wurden von 118 klinischen C. albicans Isolaten, davon 76 sensibel und 41 resistent, und 127 C. glabrata Isolaten, davon 52 sensibel und 73 resistent, eingeschlossen. Von diesen 246 Isolaten wurde anschließend eine neu entwickelte multiplex long-range PCR von acht Resistenzgenen durchgeführt. Die gesamte Sequenz der Gene ERG11, ERG3, FCY1, FUR1, GSC1, TAC1, MRR1 und UPC2 in C. albicans und ERG11, ERG3, FCY1, FUR1, FKS1, FKS2, PDR1 und MSH2 in C. glabrata wurde amplifiziert und sequenziert. Dafür wurden Primer mittels Primer3 Tool erstellt und etabliert. Anschließend wurden die Amplifikate der PCR mittels Nextera XT ® (Illumina) fragmentiert. Die Sequenzierung erfolgte mittels V3-Flowcell® am Illumina MiSeq. Ergebnisse und Conclusio In dieser Studie konnten 295 verschiedene Missense-Mutationen, dies sind Mutationen die zu einer Aminosäuresubstitution führen, in Resistenzgenen eruiert werden. Von diesen konnten 111 Mutationen mit Resistenzen assoziiert werden, da diese nur in resistenten Isolaten detektiert wurden. Bei 184 Mutationen konnte eine Relevanz für die Ausbildung von Resistenzen ausgeschlossen werden, da diese auch in sensiblen Isolaten vorkamen. In dieser Studie konnte gezeigt werden, dass die Kombination einer long-range multiplex PCR mit targeted resequencing eine einfache und zeitsparende Methode ist, um eine große Anzahl an Isolaten und Resistenzgenen zu untersuchen. Diese Studie konnte somit einen Beitrag zur Eruierung der zugrundeliegenden Resistenzmechanismen leisten. Introduction C. albicans and C. glabrata are occasionally part of the human mycobiome and both Candida species also cause opportunistic infections. In recent years, an increase in antifungal resistant Candida strains has been reported. In the case of azole resistance there are multiple resistance mechanisms known. The relevance of a single mechanism cannot be determined extensively without the investigation of the other mechanisms. Numerous studies investigating the relevance of resistance genes either deal with a single gene or use a whole genome approach with a limited number of isolates. For further research, it is important to determine the relevance of the individual mutations. Objectives The objective of this thesis is to differentiate between potential causal resistance mutations and non-causal single nucleotide variants in the resistance genes of C. albicans and C. glabrata. In addition, the relevance of the genes for the acquisition of resistance shall be determined. Thus, the aim of this study was to develop an easy method with minimal hands-on time, which allows the detection of mutations in multiple resistance genes in a high number of susceptible as well as resistant isolates. Methods In this study, we investigated 118 clinical C. albicans, consisting of 76 susceptible and 41 resistant isolates, as well as 127 C. glabrata isolates, including 52 susceptible and 73 resistant C. glabrata strains. The whole sequence of the genes ERG11, ERG3, FCY1, FUR1, FKS1, FKS2, PDR1 and MSH2 in C. glabrata and ERG11, ERG3, FCY1, FUR1, GSC1, TAC1, MRR1 and UPC2 in C. albicans were amplified via a multiplex long-range PCR and sequenced. For the multiplex long-range PCR the primers were newly designed using Primer3 Tool. After the long-range multiplex PCR, the amplicons were fragmented with Nextera XT® (Illumina). Sequencing was performed with a targeted resequencing design using the V3-Flowcell® on Illumina MiSeq Platform. Results and Conclusion We detected a total of 295 different missense mutations in resistance genes. A total of 111 mutations could be associated with resistance as they were detected only in phenotypically resistant isolates. 184 mutations could be classified as single nucleotide variants as they were detected in susceptible isolates. In this study we were able to show that simultaneously a long-range multiplex PCR combined with subsequent targeted resequencing is a simple and efficient method for sequencing many isolates and their genes. Thus, this approach enables a comprehensive overview of the relevance of different mutations in resistance genes and therefore enables the classification of the relevance of the corresponding resistance mechanisms. more...
- Published
- 2021
21. [Severe Candida sepsis in a 28-year-old female patient with initial diagnosis of diabetes mellitus and marked hyperosmolar coma]
- Author
-
S, Niel, R, Douwa, and S G, Sakka
- Subjects
Adult ,Antimykotika ,Kasuistiken ,Animycotics ,Shock, Septic ,Mycosis ,Caspofungin ,Sepsis ,Fluconazol ,Diabetes Mellitus ,Humans ,Coma ,ECMO ,Mykose ,Candida - Abstract
We report on a 28-year-old female patient who had no history of diseases and who was brought to our intensive care unit in a comatose state by the ambulance service. The clinical picture corresponded to sepsis with a massively increased blood sugar concentration ( 2000 mg/dl) as well as a pronounced skin mycosis in the groin region of the very obese patient (body mass index [BMI]: 33.7 kg/mBerichtet wird über eine 28-jährige bis dato nicht bekannt vorerkrankte Patientin, welche mit dem Rettungsdienst in komatösem Zustand auf unsere Intensivstation gebracht wurde. Klinisch bestanden das Bild einer Sepsis, eine massiv erhöhte Blutzuckerkonzentration ( 2000 mg/dl) sowie in der körperlichen Untersuchung eine ausgeprägte Hautmykose der Leistenregion der stark adipösen Patientin (BMI [Body-Mass-Index]: 33,7kg/m ). Die Sepsistherapie umfasste daher bereits ab dem Aufnahmetag eine kalkulierte antimykotische Therapie. Die Blutkulturdiagnostik bestätigte das Vorhandensein von Candida albicans sowie Candida glabrata. Trotz adäquater antiinfektiver Therapie kam es im weiteren Verlauf zur Entwicklung eines septischen Schocks mit der Notwendigkeit einer Nierenersatztherapie ab dem dritten Tag sowie eines schweren ARDS, sodass die zusätzliche Eskalation der Therapie durch eine venovenöse extrakorporale Membranoxygenierung eingeleitet wurde. Trotz aller oben genannten Maßnahmen und maximaler intensivmedizinischer Therapie entwickelte die Patientin ein progredientes Multiorganversagen. Beim Auftreten von lichtstarren Pupillen wurde eine zerebrale Computertomographie durchgeführt. Diese erbrachte den Nachweis eines ausgeprägten generalisierten Hirnödems; eine Blutung wurde ausgeschlossen. Somatosensorisch evozierte Potenziale und Elektroenzephalogramm mit Untersuchung in Wiederholung erbrachten Hinweise auf irreversible Hirnschäden. In Anbetracht dieser infausten Prognose wurden die Therapiemaßnahmen limitiert. Die Patientin verstarb am Tag 24 nach der Aufnahme auf der Intensivstation. Das Fallbeispiel zeigt, dass eine antimykotische Therapie durchaus bei klinisch begründetem Verdacht bereits initial im Rahmen der Sepsistherapie in Betracht gezogen werden sollte.Die Rolle der massiv alterierten Stoffwechselsituation mit massiver Hyperglykämie und Ketoazidose kann nicht abschließend bewertet werden. more...
- Published
- 2020
22. [Clinical picture, causative agents and diagnostics of dermatomycoses].
- Author
-
Nenoff P, Klonowski E, Uhrlaß S, Verma SB, and Mayser P
- Subjects
- Aged, Infant, Humans, Skin, Candida albicans, Candida, Onychomycosis, Tinea Capitis, Dermatitis
- Abstract
Dermatomycoses affect free skin, hairy scalp, fingernails and toenails. In addition, oral mucosa and genital mucosa can also be affected by fungal infections. The most common pathogens causing skin fungal infections are dermatophytes. They are responsible for, among others, tinea corporis, tinea capitis and onychomycosis (tinea unguium). Mainly anthropophilic dermatophytes are found as pathogens. In the case of tinea capitis-at least in Europe and in German-speaking countries-zoophilic skin fungi must also be considered. Rarely, geophilic dermatophytes can also be isolated. Yeast infections of the skin, mostly caused by Candida albicans, primarily affect the intertriginous skin areas, for example, the groin region, but also the submammary area and the spaces between the fingers and toes. Elderly patients are often affected, but also infants and, in particular, immunocompromised patients. These patient groups are also more frequently affected by oral mucosal infections caused by Candida albicans and other Candida species. Pseudomembranous candidiasis of the oral mucosa and tongue typically affects patients with HIV/AIDS. Mold infections in dermatology are relevant in onychomycosis of the big toenail. The causative agent is usually Scopulariopsis brevicaulis. Cutaneous mold infections are rare and only occur in immunocompromised patients. The mycological diagnosis of dermatomycoses is based on the microscopic, if possible fluorescence-optical detection of fungal hyphae and spores from skin scales, nail shavings and hair roots. The culture detection of dermatophytes, yeasts and molds allows the identification of the causative fungal species, but often fails, especially in patients who have already been treated with antifungal agents. In view of the high sensitivity and specificity of the molecular methods for fungal detection compared to culture, polymerase chain reaction (PCR) must realistically be regarded as the gold standard for dermatophytosis diagnostics. However, it should not be neglected that the three pillars of diagnostics-preparation, culture, PCR-currently deliver the best results., (© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.) more...
- Published
- 2022
- Full Text
- View/download PDF
23. Caspofungin nach Transplantation solider Organe in Deutschland.
- Author
-
Lichtenstern, C., Pratschke, J., Schulz, U., Schmoeckel, M., Knitsch, W., Kaskel, P., Krobot, K.J., Weigand, M.A., and Winkler, M.
- Subjects
- *
ANTIFUNGAL agents , *DRUG efficacy , *COMMUNICABLE disease treatment , *MYCOSES , *INFECTION , *ASPERGILLOSIS , *CASE studies , *PATIENTS - Abstract
Background: This study was a pre-planned country-specific secondary analysis of results in Germany from a multinational multicenter observational study to retrospectively evaluate clinical outcomes with caspofungin in patients with probable and proven invasive fungal infection following solid organ transplantation (SOT). Methods: Data were retrospectively collected on a single episode of invasive fungal infection (IFI) in patients who had a SOT between January 2004 and June 2007. Effectiveness was reported as the proportion of patients who received at least five doses of caspofungin with a favorable (complete or partial) response. Safety was assessed for patients who received at least one dose of caspofungin. Descriptive statistics were employed for all evaluations. Results: A total of 41 SOT patients (27 male, 14 female; median age 56 years, median APACHE II score at start of caspofungin therapy 23) were enrolled from 5 sites in Germany. Organs transplanted were mainly heart (51%) and liver (46%). Prevalent risk factors for IFI at baseline were use of central venous catheter (37 out of 41 patients, 90%), steroid use (37 out of 41 patients, 90%), recent stay in intensive care (36 out of 41 patients, 88%),and duration of SOT procedure >5 hours (21 out of 41 patients, 51%). Candidiasis was diagnosed in 34 patients (83%) and aspergillosis in 10 patients (24%). The lungs were the most common site of IFI (21 out of 41, 51%). Caspofungin as monotherapy was received by 28 patients (68%); 6 patients (15%) received caspofungin as salvage therapy for IFI, in most cases because they were refractory to prior antifungal drugs. Immunosuppressants were administered with caspofungin in 39 out of 41 patients (95%). In subjects with at least 5 doses of caspofungin (modified intention to treat population) the favorable response rate at the end of caspofungin therapy was 88% overall, 29 out of 33 patients; 95% confidence interval (95%-CI) 72-97%), 86% (19 out of 22 patients) with monotherapy and 91% (10 out of 11 patients) with combination therapy. No (serious) adverse events or drug interactions related to treatment with caspofungin were reported. The overall survival rate was 79% (26 out of 33 patients; 95%-CI 61-91%) at 7 days after completion of caspofungin treatment. Conclusion: Caspofungin was found to be an effective treatment of probable and proven invasive fungal infections in patients following SOT in Germany. [ABSTRACT FROM AUTHOR] more...
- Published
- 2010
- Full Text
- View/download PDF
24. Rotes Auge und Visusstörung zwei Monate nach Ösophagusresektion mit kompliziertem postoperativem Verlauf.
- Author
-
Richter, J. C., Waldegg, G., and Richter, K. K.
- Subjects
- *
EYE infections , *CANDIDA tropicalis , *ANTI-infective agents , *HOSPITAL care , *OPHTHALMOLOGY , *PHARMACEUTICAL microbiology , *THERAPEUTICS - Abstract
A patient with a red, painful eye and gradual visual impairment is examined ophthalmologically. Culture of the vitreal aspirate yields Candida tropicalis. Subsequent medical evaluation reveals that during an acute hospitalization eight weeks prior positive blood cultures for Candida had been reported but not acted on, despite a high risk constellation of operative therapy, intensive care unit treatment, central catheters, parenteral nutrition and broad spectrum antibiotics. Diagnosis and treatment of candidemia with a focus on candida endophthalmitis is discussed. [ABSTRACT FROM AUTHOR] more...
- Published
- 2008
- Full Text
- View/download PDF
25. Fall-Bericht: Analyse der kritischen Zeitverzögerungen vom Fieberanstieg bis zur ersten Antimykotika-Gabe bei der Diagnostik einer Candidämie.
- Author
-
Kappe, Reinhard, Fuchs, Erika, Gorges, Alexander, and Rimek, Dagmar
- Subjects
- *
MICROBIOLOGICAL techniques , *ANTIFUNGAL agents , *ANTI-infective agents , *HOSPITAL care - Abstract
In a secondary care hospital in Germany with an in-house microbiology laboratory, an 84-year-old female patient with candidemia was selected for determination of the time periods required for each diagnostic step preceding the application of the first dose of antimycotic treatment. The total time from the beginning of fever to the first dose of fluconazole was 25 hours and 10 minutes. The largest delay occurred between the positive signal of the blood culture bottle during the night and the start of the work-up of the positive blood culture bottle in the morning. Improvements appear to be possible in both clinical and laboratory settings by optimizing pre-analytical, analytical, and post-analytical procedures. [ABSTRACT FROM AUTHOR] more...
- Published
- 2008
- Full Text
- View/download PDF
26. Einfluss einer Antimykotika-Prophylaxe auf die gastrointestinale Besiedlung mit Sprosspilzen bei hämatologischen Patienten.
- Author
-
Rimek, Dagmar, Redetzke, Kristin, and Kappe, R.
- Subjects
- *
DENTAL prophylaxis , *ANTIFUNGAL agents , *CANDIDA , *GASTROINTESTINAL system , *NEUTROPENIA , *HEMATOLOGY , *CANDIDIASIS - Abstract
Patients with haematological malignancies are at high risk for developing invasive Candida infections. They are often colonised with Candida spp. in the gastrointestinal (GI) tract. In order to prevent infection, the prophylactic use of antifungal agents has been established. The widespread use of fluconazole may lead to the emergence of resistant Candida isolates. We studied the yeast colonisation of the GI tract in patients with haematological malignancies receiving antifungal prophylaxis (AP) in comparison with healthy controls. The study cohort included 46 neutropenic patients with 52 stool samples under 52 episodes of AP and 110 healthy controls. The patients received amphotericin B orally ( n = 8), amphotericin B and fluconazole ( n = 7), amphotericin B and itraconazole ( n = 5), fluconazole orally ( n = 15) and itraconazole orally ( n = 17). Yeasts were cultured from the stool samples of 63.5% of the patients and 60% of the controls with a mean yeast load of 1.6 × 103 and 0.4 × 103 cfu g−1, respectively ( P = 0.045). Patients and controls had a low faecal yeast load of 103 to 104 cfu g−1 in 19.3% and 37.3%, respectively ( P = 0.021), and yeast overgrowth of >105 cfu g−1 in 28.9% and 10.9%, respectively ( P = 0.004). The rate of Candida albicans was 32.6% and 54.1% in the patients and controls, respectively ( P = 0.021). The rates of fluconazole-resistant yeast species were higher in the patient group than in the control group: C. glabrata 20.9% vs. 11.7% ( P = 0.168), C. krusei 25.6% vs. 4.7% ( P = 0.001). Not a single patient under AP suffered from proven or probable invasive candidosis. In conclusion, oral AP in haematological patients resulted in a higher colonisation rate with fluconazole-resistant Candida species but efficiently prevented invasive candidosis. [ABSTRACT FROM AUTHOR] more...
- Published
- 2006
- Full Text
- View/download PDF
27. Vaginale Candidose.
- Author
-
Hof, H.
- Abstract
Copyright of Der Gynäkologe is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2006
- Full Text
- View/download PDF
28. RezidivierendeCandida-Sepsis mit protrahiertem Lungenversagen und schwerer Leberdysfunktion.
- Author
-
Lewejohann, J., Hansen, M., Zimmermann, C., Muhl, Elke, and Bruch, H. P.
- Subjects
- *
SEPSIS , *COMMUNICABLE diseases , *BLOOD diseases , *MYCOSES , *CANDIDA , *LIVER diseases , *DISEASE relapse , *MEDICAL mycology - Abstract
Systemic mycoses, especially pulmonary diseases and septicemia are observed increasingly at intensive care units. Essential risk factors for development of candidosis are the expanded use of antibiotics and immunocompromised patients, caused either as a result of a severe underlying disease or iatrogenicly induced after organ transplantation.Candida albicansis the most frequent pathogen in microbiological findings. Blood cultures are only positive in massive fungemia.We report a 50-year-old patient with recurrentCandida-septicemia: rupture of the distal esophagus after dilatation because of cardiac achalasia with mediastinal emphysema and mediastinitis. Severe acute respiratory distress syndrome after aspiration with septic shock and acute renal failure at the beginning. Long-term mechanical ventilation, continuous renal replacement therapy and multifarious antibiotic therapy. Early microbiological samples of several positive blood cultures and bronchoalveolar lavages revealed the presence ofCandida albicans. In the further clinical course, detection ofPseudomonasspecies in bronchoalveolar lavages andStaphylococcias well asEnterococciin a number of positive blood cultures. Later on development of a severe liver dysfunction with test results that showed an intrahepatic cholestasis. Because of coagulation failure commencement of artificial liver support with the MARS®-system (molecule adsorbent recirculating system). Decrease of high bilirubin levels was accompanied by improvement of clinical condition of the patient. In the following course, repeated severe systemic infections with phases of septicemia or rather septic shock and detection ofCandidain several positive blood cultures and bronchoalveolar lavages. In each case increasing bilirubin levels with signs of intrahepatic cholestasis and each time improvement with antimycotic therapy (voriconazol, caspofungin and fluconazol). The patient showed more and more signs of immunodeficiency in the sequel.The clinical appearance of candidosis is manifold. SystemicCandidainfections are frequent in patients with immunodeficiency. A recurrentCandidasepticemia with prolonged respiratory failure and severe liver dysfunction in form of cholestatic hepatosis, that improved several times with antimycotic therapy in combination with evidence based intensive care measures and artificial organ support is a comparatively rare event. [ABSTRACT FROM AUTHOR] more...
- Published
- 2005
- Full Text
- View/download PDF
29. Diagnostische Wertigkeit des Nachweises von Antikörpern gegenCandida-Keimschlauchantigene bei einer Patientin mit hepatolienaler Candidose.
- Author
-
Wulf, G. G., Conradi, I., and Rüchel, R.
- Subjects
- *
SEROLOGY , *CANDIDA , *MYELOID leukemia , *MYCOSES , *IMMUNOGLOBULINS , *ANTIGENS , *ENZYME-linked immunosorbent assay , *IMMUNOGLOBULIN M , *IMMUNOGLOBULIN G - Abstract
In the case of a 53-year-old woman with acute myeloid leukaemia and fever in late aplasia after chemotherapy, invasive mycosis with characteristic involvement of liver and spleen was diagnosed. For the serological identification ofCandidain the early phase of the infection, methods for the detection of antibodies againstCandidaantigens were compared. By ELISA-based detection of IgM and IgG antibodies against a mixture ofCandidaantigens (ESR 117G and 117M, Virion-Serion, Würzburg, Germany) evidence for invasive candidosis was obtained significantly earlier (22 days) when compared with the immunofluorescence detection of IgG antibodies againstCandida albicansgerm tube antigens (Vircell, Granada, Spain). In the case of this patient, the detection of a humoral response againstCandidagerm tube antigens was of little diagnostic value. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
30. Mykoserologische Untersuchungen an chirurgischen Intensivtherapie-Patienten und beiCandida-Ösophagitis.
- Author
-
Bernhardt, J. and Ludwig, K.
- Subjects
- *
CANDIDA , *SEROLOGY , *IMMUNOLOGY , *CRITICAL care medicine , *HEMAGGLUTINATION tests , *IMMUNOGLOBULINS , *CULTURES (Biology) , *CANDIDIASIS - Abstract
We retrospectively analysed the results ofCandidaserological testing of 126 surgical intensive care patients. There were high numbers of patients which were mycoserologically positive (haemagglutination test HAT 86.4%, immunoglobulin subclasses 85.3%). Positive microbiological cultures ofCandidaspp. were found in 43.7% of the patients. Patients with positive cultural findings had an increased HAT titre in 83.9% and increased immunoglobulins in 74.2%. These patients were suspected to have aCandidainfection. The correlation to higher titres was much closer in patients with an invasiveCandidainfection like candidaemia and oesophagitis. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
31. Diagnose systemischerCandida-Infektionen: Bewertung der Serologie, der Molekularbiologie und des D-Arabinitol-Nachweises.
- Author
-
Bär, W., Beyreiß, B., Rebentisch, G., and Juretzek, T.
- Subjects
- *
DIAGNOSIS , *CANDIDIASIS , *SEROLOGY , *MOLECULAR biology , *CRITICAL care medicine , *ANTIGENS , *IMMUNOGLOBULINS , *POLYMERASE chain reaction - Abstract
In order to diagnose systemicCandidainfection in ICU patients, several methods were compared. In the first round, antigens and antibodies of 104 patients were investigated. Seventeen patients were infected; in nine of these patients a positive antigen was detected; elevated antibodies were detected in 11 patients. Only 42 patients were colonized. In this group, one positive antigen and six elevated antibody titres were detected. Combining these results, the sensitivity of the antigen only (58.5%) or the antibodies only (52.9%) increased to 100%. In the second round (n = 83 patients) the D-arabinitol/L-arabinitol quotient was also determined in the urine. 18.1% of the patients had elevated antibodies and 26.5% elevated D-arabinitol/L-arabinitol quotients. In the third round, PCR was also applied (n = 27 patients). Five patients had elevated D-arabinitol/L-arabinitol quotients and one of these had a positive PCR result. In conclusion, serological methods (antigen and antibody detection) should only be applied in strictly selected patients. In uncertain cases, the addition of PCR or determination of D-arabinitol/L-arabinitol might be helpful. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
32. Candida- undAspergillus-Antikörper-ELISA– Erwartungswerte positiver Antikörpernachweise aus Seren der klinisch-mykologischen Routinediagnostik.
- Author
-
Fegeler, W. and Kipp, F.
- Subjects
- *
ENZYME-linked immunosorbent assay , *CANDIDA , *CANDIDIASIS , *ASPERGILLUS , *IMMUNOGLOBULINS , *IMMUNOGLOBULIN M , *IMMUNOGLOBULIN G , *IMMUNOGLOBULIN A - Abstract
Based on the ELISA results of more than 15000 serum samples of clinical mycological routine diagnostics, the expected frequency of positive antibody ELISA results within the immunoglobulin classes IgM, IgG and IgA was determined, to optimize the diagnostic assessment of first or single result ofCandidaorAspergillusantibody ELISA. In general diagnostics the expected frequency of positive antibody ELISA results of the first sample within the immunoglobulin classes were as follows:Candidaantibody IgM 6.1%; IgG 6.0%; IgA 2.1% andAspergillusantibody IgM 11.4%; IgG 22.1% and IgA 5.1%, respectively. Using theCandidaantibody ELISA as confirmation test only, percentages of positive antibody results in the first sample were 2.5 to 3 times higher than in general diagnostics. In follow-up examinations theCandidaantibodies showed different kinetics within the immunoglobulin classes compared to those of theAspergillusantibodies. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
33. Candida-spezifische Antikörper bei Intensivtherapiepatienten und Nichtintensivtherapiepatienten.
- Author
-
Knoke, M. and Bernhardt, H.
- Subjects
- *
IMMUNOGLOBULINS , *CANDIDA , *HEMAGGLUTINATION tests , *IMMUNOASSAY , *CRITICAL care medicine , *IMMUNOGLOBULIN M , *IMMUNOGLOBULIN G , *IMMUNOGLOBULIN A , *MEDICAL screening - Abstract
The titres of indirect anti-Candidahaemagglutination test (C-HAT) and specific immunoglobulins C-IgM, C-IgG and C-IgA in 328 intensive care (IT) patients and 166 non-intensive care (NIT) patients were compared by statistical test methods. Positive correlations were found between values of C-HAT and all threeCandida-specific immunoglobulins. At an interval of≤7 days in the first patient group only, the changes in the course of titres were statistically highly significant. For C-IgM the short-term increase of titres can be interpreted in the sense of happened mycotic infection in connection with the clinical picture. In IT patients we found an average increase of C-IgM at 259.3, C-IgG at 174.7, C-IgA at 59.8 U ml−1 and of three titre steps in C-HAT. In our experience of diagnostics ofCandidainfections in intensive care area with non-neutropenic patients the short-term determination of the anti-Candidaimmunoglobulin subclasses C-IgM and C-IgG and of C-HAT as screening test should not be neglected. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
34. Performance desCandida-Mannan-Antigennachweises bei Patienten mit Fungämien.
- Author
-
Rimek, D., Redetzke, K., Singh, J., Heinrich, K., and Kappe, R.
- Subjects
- *
ENZYME-linked immunosorbent assay , *CANDIDA , *CANDIDIASIS , *ANTIGENS , *MYCOSES , *YEAST , *SERUM , *CULTURES (Biology) - Abstract
For several years, the Platelia® Candidamannan antigen enzyme immunoassay (CandidaEIA) has been commercially available as a diagnostic test for invasive candidosis. We evaluated theCandidaEIA with patients with proven fungemia caused by yeasts from which at least one serum sample was available. Fifty-nine patients with 121 serum samples were included in the study. Sixty-one different yeast strains were isolated from positive blood-cultures. TheCandidaEIA was positive (n = 35) or borderline positive (n = 8) in 43 of 59 patients with fungemia, resulting in an overall sensitivity of 73%. For the different yeast species, the following sensitivities were calculated:Candida albicans30 of 39 (77%),Candida glabrata7 of 11 (64%),Candida parapsilosis1 of 3,Candida tropicalis2 of 2,Candida kefyr2 of 2,Candida lipolytica0 of 1,Candida lusitaniae1 of 1,Candida krusei1 borderline positive of 1,Saccharomyces cerevisiae1 of 1. In six patients the antigen levels over time were evaluable. In three cases the antigen was positive 3–4 days before the day the blood culture was drawn, in one case on the same day, and in two cases 2 and 5 days afterwards. In conclusion, theCandidaEIA was suitable for the detection of fungemia due to the major facultatively pathogenic yeast species. The test was positive in about half of the patients before blood cultures became positive. In these cases, it contributed to an early diagnosis of invasive candidiasis. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
35. Erfahrungen mit dem Platelia® CandidaELISA zur Diagnostik invasiverCandida-Infektionen bei neutropenischen Patienten.
- Author
-
Rimek, D., Redetzke, K., Steiner, B., and Podbielski, A.
- Subjects
- *
DIAGNOSIS , *CANDIDIASIS , *CANDIDA , *MYCOSES , *IMMUNE system , *ENZYME-linked immunosorbent assay , *HEMATOLOGICAL oncology , *NEUTROPENIA , *SERUM - Abstract
InvasiveCandidainfections (IC) belong to the most important opportunistic fungal infections in immunocompromised patients. IC is difficult to diagnose, because clinical symptoms are nonspecific and cultural methods lack sensitivity or specificity. We evaluated the Platelia® Candidaenzyme immunoassay (CandidaEIA) for the diagnosis of IC in patients with haematological malignancies. A total of 62 neutropenic patients with 469 serum samples were included in the study.Candidacolonization was monitored by weekly cultures of mouth washings, urine, and stool samples. Yeasts were grown from samples of 42 patients (68%), mainlyCandida albicans(50%), followed byCandida glabrata(23%) andCandida krusei(20%). According to the criteria of the EORTC/NIH, the patients were categorized: (1) 3 patients with proven IC; (2) 6 patients with probable IC; (3) 34 patients colonized withCandida; (4) 19 patients withoutCandidacolonization and without IC. In the patient categories (1) to (4), 3/3 (100%), 3/6 (50%), 20/34 (59%), and 7/19 (37%) patients wereCandidaEIA positive (>0.5 ng/ml) in at least one serum sample. The sensitivity of the assay for the detection of proven IC was 100%, for proven and probable IC 67%, the specificity was 49% for both groups. An increase of the cut-off value to 2.0 ng/ml raised the specificity to 61%, but lowered the sensitivity to 56%. In conclusion, the Platelia® CandidaEIA does not discriminate betweenCandidacolonization and probable invasive infection in haematological patients. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
36. Die Bedeutung der Interleukine und des Candida-IgE bei der chronisch rezidivierenden Vulvovaginalcandidose.
- Author
-
Weissenbacher, E. R., Weissenbacher, T., and Spitzbart, H.
- Subjects
- *
CANDIDIASIS , *VAGINAL diseases , *CHRONIC diseases , *CANDIDA , *YEAST , *INTERLEUKINS , *PROSTAGLANDINS , *IMMUNOGLOBULIN E - Abstract
We examined 104 patients with chronic recurrent vulvovaginal candidosis; 41 healthy women were selected for the control group. Vaginal samples were taken, and yeasts were grown and tested forCandidastrains: 29.8% of samples containedCandidaspp.; two of the control women were infected. We also identified interleukin IL-4, 5 and 13, but there was only significant increase in IL-4. In addition, prostaglandin E2, whole IgE andCandida-specific-IgE was identified. Also here prostaglandin E2 and theCandidaIgE were significantly higher in comparison with the control group, while whole IgE showed no significant increase. This resulted in an allergic component in the chronic recurrent vulvovaginal candidosis, which suggested that therapy should be reconsidered. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
37. Zur Bewertung der Zellwandantigen-basiertenCandida-Serologie.
- Author
-
Müller, J. and Melchinger, W.
- Subjects
- *
IMMUNOGLOBULINS , *CANDIDA , *SEROLOGY , *BIOCHEMISTRY , *ANTIGENS , *BACTERIAL cell walls , *IMMUNE system , *HOST-parasite relationships , *PATHOGENIC microorganisms - Abstract
The article reviews the state of the art in detecting anti-Candidaantibodies directed against cell wall mannans. Experience in this field was collected over more than four decades. The mannan antigens ofCandidaspp. are well characterized serologically and biochemically.Candidamannans are immunogenically potent antigens to which the host's immune system reacts regularly. The human host is not immunologically naïve towardsCandida albicans. Clinical and laboratory evaluation of methodologies detecting anti-Candidaantibodies must essentially regard the pathogenetic particularities of candidaemia and candidosis with their opportunistic characters. [ABSTRACT FROM AUTHOR] more...
- Published
- 2004
- Full Text
- View/download PDF
38. Therapie schwerer Pilzinfektionen.
- Author
-
Battegay, M. and Flückiger, U.
- Abstract
Copyright of Der Internist is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2003
- Full Text
- View/download PDF
39. [Acute on chronic renal failure in a 62-year-old man with ANCA-associated vasculitis]
- Author
-
C, Schroeder, H, Schenk, A, Khalifa, J H, Braesen, and S, von Vietinghoff
- Subjects
Male ,Antifungal Agents ,Biopsy ,Candidiasis ,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis ,Acute Kidney Injury ,Middle Aged ,Antibodies, Antineutrophil Cytoplasmic ,Treatment Outcome ,Acute Disease ,Humans ,Kidney Failure, Chronic ,Nephritis, Interstitial ,Cyclophosphamide ,Immunosuppressive Agents ,Candida - Abstract
We describe a patient with ANCA (antineutrophil cytoplasmic antibodies) associated vasculitis and acute-on-chronic renal failure. He had initially presented with severe pulmonary hemorrhage and anuric renal failure and improved rapidly with immunosuppressive therapy. Repeat renal biopsy revealed candida interstitial nephritis. Candida was also detected in bronchoalveolar lavage. Kidney function improved with long-term antifungal therapy. This report adds induction therapy for ANCA vasculitis to the conditions where invasive candidal infections including nephritis need to be considered. more...
- Published
- 2019
40. Gastrointestinale Mikroökologie des Menschen und Candida.
- Author
-
Knoke, M.
- Subjects
- *
CANDIDIASIS , *LEAVENING agents , *SMALL intestine , *INDUSTRIAL microbiology , *YEAST , *GASTROINTESTINAL system - Abstract
Microecology looks for the relationships between microorganisms and their natural environment in definite sites and their physiological and pathological effects. From birth Candida spp. are often but not always detectable in the human gastrointestinal tract. In cases of reduced defense the tract may be a source of infection to the macroorganism. In healthy subjects the incidence of Candida is between 23% and 76% in quantities between 10²-104 CFU/ml or g dependent on site. Evidence is most frequent in oral cavity and faeces. Tolerance for Candida spp. is different in the stomach and duodenum due to differences in acidity. Changes in the occurrence of Candida spp. are possible depending on age, different diseases and exogenous influences as nutrition, stress and drugs. In an endocrine stress model we found no yeasts in the duodenal juices of 7 subjects before and after stress situation, but a clear decrease of yeasts in the faeces. The formation of metabolic products by Candida is secondary to the whole of microbial fermentation in the human orointestinal tract. Colonizing strains of C. albicans are normally present in small or moderate numbers and only they are regarded as part of the resident gastrointestinal microflora [ABSTRACT FROM AUTHOR] more...
- Published
- 1999
- Full Text
- View/download PDF
41. Zur Taxonomie und Ökologie der Gattung Candida.
- Author
-
Schauer, F. and Hanshke, R.
- Subjects
- *
CANDIDIASIS , *NUCLEIC acids , *DNA , *GENES , *ALCOHOLS (Chemical class) , *METHANOL - Abstract
Candida is a heterogeneous genus which contains about a quarter of all yeast species. It includes not only species of uncertain affiliation but also unrelated strains whose phylogenetic relationships have not been resolved. A great variety of CoQ types are present in the genus, the mol % G+C ranges from 30-63%, and species that were found to sporulate have teleomorphic counterparts in 11 different genera. Candida species are mainly associated with plants, rotting vegetation, with insects which feed on plants or with food. In line with this, 71% of Candida species utilize xylose (wood degradation), 57% of species use cellobiose (cellulose degradation), 29% oxidize aliphatic hydrocarbons (components of plant cuticula), 27% of species degrade starch as a plant storage material, and 7% utilize methanol as a possible metabolite from pectin catabolism, 85% of species require individual vitamins produced mainly in plant materials. 65% of Candida species are not able to grow at temperatures of 37° C. In comparison only relatively few species occur normally in humans and other warm blooded animals. About 16% of type strains and selected strains for comparative purposes (CBS) were isolated from human specimens. Perhaps up to 10% of Candida species may be of medical importance, though this has so far only been clearly demonstrated for less than 5% of currently known species. [ABSTRACT FROM AUTHOR] more...
- Published
- 1999
- Full Text
- View/download PDF
42. Standorte für Candida aus medizinisch-hygienischer Sicht.
- Author
-
Blaschke-Hellmessen, Renate
- Subjects
- *
CANDIDIASIS , *CANDIDA albicans , *NUCLEIC acids , *DNA , *GENES , *ALCOHOLS (Chemical class) - Abstract
The at present acknowledged 163 species of the genus Candida are living in different habitats. Agents of human candidosis have a comparatively restricted natural distribution, and have been discovered primarily in association with men and animals. Candida albicans holds and exceptional position opposite to the nearly 20 non-C. albicans-species with medical importance. Primary habitat is the digestive tract of men and warm-blooded animals. C. albicans is not ubiquitously distributed in the nature. Carriers of Candida may contaminate their immediate environment with yeasts, but that contamination does not usually spread far. C. albicans survives poorly on dry surfaces, a little bit longer in moist materials. Some non-C. albicans-species have their habitat also in the digestive tracts of men and animals, but different to C. albicans they are also ubiquitously distributed in the surroundings (soil, plants, foods, forages) and are much more resistent to environment influences. The most important source of Candida species in human diseases is endogenous. The via exogen contamination arising mycoses are involved above all by non-C. albicans-species. The different habitats of the Candida species are decisive for the direct and indirect transmission of yeasts to humans and also for the preventive measures against endogenous and exogenous nosocomial Candida mycoses. [ABSTRACT FROM AUTHOR] more...
- Published
- 1999
- Full Text
- View/download PDF
43. Candida albicans im elektronenoptischen Bild.
- Author
-
Müller, J.
- Subjects
- *
CANDIDA albicans , *CANDIDA , *CANDIDIASIS , *MICROSCOPY , *CRYOMICROSCOPY , *MYCOSES - Abstract
The multiplicity of information which electronmicroscopy has contributed to our knowledge of Candida albicans and its relationship to the human host is reviewed and by means of examples presented. [ABSTRACT FROM AUTHOR] more...
- Published
- 1999
44. Strukturelle und funktionelle Charakterisierung pilzlicher Zellwandproteine für Adhäsion und Integritätswahrnehmung
- Author
-
Lutterbach, Bernard and Mösch, Hans-Ulrich (Prof. Dr.)
- Subjects
Pwp ,Heparin ,Candida glabrata ,Saccharomyces cerevisiae ,PA14 ,Adhesins ,Life sciences ,Glykosaminoglyka ,Yeast ,Zellwand ,Adhäsine ,Wsc ,Adhäsionsdomänen ,glycosaminoglycan ,Adhesion domain ,Biowissenschaften, Biologie ,Candida ,Hefen ,heparin ,Zellwandintegrität ,Cell wall integrity ,Hefeartige Pilze ,ddc:570 - Abstract
Die humanpathogene Hefe Candida glabrata verfügt über eine Familie von sieben Pwp Proteinen (PA14 domain containing cell wall protein) mit einem modularen Aufbau wie er typischerweise in pilzlichen Adhäsinen zu finden ist. Pilzliche Adhäsine sind sekretierte Proteine, die üblicherweise aus drei Regionen aufgebaut sind: Einer Nterminalen domäne für die Adhäsion (A-domäne), einem zentralen Segment mit einer variablen Anzahl repetetiver, hoch glycosylierter und Serin-/Threonin-reicher Abschnitte, sowie einer C-terminalen Region mit einem GPI-Anker (glycosylphosphatidylinositol) für die Befestigung in der Zellwand. Solche Proteine werden auch GPI-CWP Adhäsine genannt (GPI-anchored cell wall-associated proteins). Im ersten Teil dieser Arbeit wurden die Kristallstrukturen der A-Domänen der beiden Paraloge Pwp1A und Pwp5A gelöst, welche einen neuen und detaillierten Einblick in strukturelle Merkmale der PwpA domänen geben. Überraschenderweise haben PwpA Domänen anstatt einer Bindetasche zur Erkennung terminaler Glykane, wie bei anderen GPI-CWP Adhäsionsdomänen üblich, eine exponierte Kalzium-Bindestelle. Außerdem scheint die strukturelle Stabilität von PwpA Domänen signifikant niedriger zu sein als bei anderen PA14 Domänen, wodurch sie empfindlicher gegenüber äußeren Faktoren wie Ionenstärke oder pH sind. Eine Pwp1A/Pwp5A strukturbasierte Modellierung aller PwpA domänen erlaubt zudem einen detaillieten strukturellen Vergleich der gesamten Pwp Familie. Analysen mittels Glykan Arrays mit fluoreszenzmarkierten PwpA Domänen ermöglichten die Identifizierung von Glykosaminoglykan als Gruppe möglicher Liganden und somit ein bisher unbekanntes Substrat für GPI-CWPs von C. glabrata. Mithilfe isothermaler Titrationskalorimetrie konnte gezeigt werden, dass Pwp1A ein synthetisches Glykosaminoglykan-Pentasaccharid mit niedriger mikromolarer Affinität bindet. Diese Ergebnisse sind relevant, da zahlreiche Bakterien, Viren und Parasiten verschiedene Adhäsionsproteine nutzen um während der Pathogenese und Wirtskolonisierung an Glykosaminoglykan zu binden. Im zweiten Teil dieser Arbeit wurde die Kristallstruktur der Cystein-reichen Domäne (CRD) des Sensorproteins Wsc1 von S. cerevisiae gelöst. Die CRD von Wsc1 liegt in der Zellwand und erkennt hier vermutlich mechanischen Stress, was zum SensorClustering und der Aktivierung eines Signalwegs führt, der ein Programm zur Instandhaltung der Zellwandintegrität aktiviert. Durch die Kristallstruktur der Wsc1CRD wird ersichtlich, dass diese Domäne durch vier Disulfidbrücken strukturell sehr rigide ist. Außerdem verfügt die Wsc1-CRD über drei Oberflächen-exponierte Cluster von Resten aromatischer Aminosäuren. Diese Strukturmotive könnten entscheidend für hydrophobe Wechselwirkungen von Wsc1 Sensoren sein, was wiederum das Clustering von Wsc1 Domänen und die Auslösung von nachgeschalteten Signalen ermöglicht., The human pathogenic yeast Candida glabrata harbors a family of seven PA14 domaincontaining cell wall proteins (Pwp) with a similar modular structure typically found in fungal adhesins. Fungal adhesins are secreted proteins that usually consist of an Nterminal domain for adhesion (A-domain), a large central segment comprised of a variable number of highly glycosylated, serine- and threonine-rich repeats (B-Domain), and a C-terminal region carrying a GPI (glycosylphosphatidylinositol) anchor required for attachment to the cell wall. Therefore, these proteins are also referred to as GPICWP (GPI-anchored cell wall-associated proteins) adhesins. In the first part of this work, the crystal structures of the A-domains of the two paralogs Pwp1A and Pwp5A were elucidated, giving a novel and detailed insights into structural features of PwpA domains. Surprisingly, PwpA domains have an exposed calcium-binding site, rather than a binding pocket for terminal glycan recognition typically found in other GPI-CWP adhesion domains. In addition, the structural rigidity of PwpA domains appears to be significantly lower than that of other PA14 domains, making them more sensitive to environmental stresses, caused by e.g. changes in ionic strength or pH. Also, the Pwp1A/Pwp5A structure-based modeling of all other PwpA domains allowed a detailed structural comparison of the whole Pwp family. Glycan array screening with various fluorescently labeled PwpA domains furthermore allowed to identify glycosaminoglycan as a possible group of ligands and a previously unknown host substrate for GPI-CWPs of C. glabrata. In the case of Pwp1A, isothermal titration calorimetry revealed that this adhesion domain is able to bind a synthetic heparin pentasaccharide with low micromolar affinity. These results are relevant, because numerous bacteria, viruses and parasites are known to bind to glycosaminoglycan via a variety of adhesive proteins during host colonization and pathogenesis. As such, these findings represent the first example for heparan-sulfate mediated adhesion by a fungal pathogen. In the second part of this work, the crystal structure of the cysteine-rich domain (CRD) of the cell surface sensor protein Wsc1 of S. cerevisiae could be solved. The CRD of Wsc1 is embedded in the cell wall and has been suggested to detect mechanical stress, leading to Wsc1 sensor clustering and activation of a signaling pathway that confers the execution of a cell wall integrity maintenance program. The structure of the Wsc1-CRD shows that this domain contains four disulfide bonds and therefore is structurally highly rigid. The Wsc1-CRD also harbors three clusters of surface-exposed, aromatic amino acid residues, indicating that these structural motifs could be crucial for mediating hydrophobic interactions upon sensor activation, which allows the clustering of Wsc1 sensor domains and triggers downstream signaling events. more...
- Published
- 2019
45. Das Verhalten von Sproßpilzen am nicht verhornenden Plattenepithel.
- Author
-
Schnell, J. and Voigt, W.
- Abstract
Copyright of Archiv für Gynäkologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 1974
- Full Text
- View/download PDF
46. 91. Prophylaktische Dekontamination der Pilze.
- Author
-
Seeliger, H. and Vögtle-Junkert, U.
- Abstract
Copyright of Langenbecks Archiv fuer Chirurgie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 1978
- Full Text
- View/download PDF
47. [Severe Candida sepsis in a 28-year-old female patient with initial diagnosis of diabetes mellitus and marked hyperosmolar coma].
- Author
-
Niel S, Douwa R, and Sakka SG
- Subjects
- Adult, Candida, Coma etiology, Coma therapy, Humans, Diabetes Mellitus, Sepsis complications, Sepsis diagnosis, Sepsis therapy, Shock, Septic therapy
- Abstract
We report on a 28-year-old female patient who had no history of diseases and who was brought to our intensive care unit in a comatose state by the ambulance service. The clinical picture corresponded to sepsis with a massively increased blood sugar concentration (> 2000 mg/dl) as well as a pronounced skin mycosis in the groin region of the very obese patient (body mass index [BMI]: 33.7 kg/m
2 ) in the physical examination. The treatment of sepsis was initially supplemented by a calculated antifungal treatment. The blood culture diagnosis confirmed the presence of Candida albicans and Candida glabrata. Despite adequate anti-infective treatment, the patient developed a septic shock in the further course, so that the additional escalation of treatment was initiated by renal replacement therapy on the second day and venovenous extracorporeal membrane oxygenation because of an ARDS. Despite all of these measures and maximum intensive care treatment, the patient developed a progressive multiple organ failure. When the pupils became rigid to light, a cerebral computed tomography was carried out. This showed evidence of a severe cerebral edema without signs of cerebral bleeding. Multiple examinations of somatosensory evoked potentials and electroencephalograms showed signs of irreversible brain damage. In view of this poor prognosis the therapeutic measures were limited. The patient died on day 24 after admission to the intensive care unit. The case study shows that antifungal treatment should definitely be considered in the context of sepsis treatment if there is a clinically justified suspicion.The role of the severely altered metabolic situation with massive hyperglycemia and ketoacidosis cannot be finally assessed., (© 2021. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.) more...- Published
- 2022
- Full Text
- View/download PDF
48. Unklarer Iristumor.
- Author
-
Rueping, J., Klingenstein, A., Wagener, J., Kampik, A., and Kook, D.
- Abstract
Copyright of Der Ophthalmologe is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) more...
- Published
- 2013
- Full Text
- View/download PDF
49. [Invasive Candida infections in liver cirrhosis]
- Author
-
A, Koch and F, Tacke
- Subjects
Liver Cirrhosis ,Antifungal Agents ,Humans ,Candidiasis, Invasive ,Candida - Published
- 2017
50. [On the treatment of candiduria and nitroxoline sensitivity of Candida isolates]
- Author
-
Winfried, Vahlensieck
- Subjects
Antifungal Agents ,Treatment Outcome ,Urinary Tract Infections ,Anti-Infective Agents, Urinary ,Candidiasis ,Humans ,Nitroquinolines ,Candida - Published
- 2017
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.